{"id":17063,"date":"2026-03-26T08:37:27","date_gmt":"2026-03-26T08:37:27","guid":{"rendered":"https:\/\/www.clinomic.ai\/?p=17063"},"modified":"2026-06-18T08:24:02","modified_gmt":"2026-06-18T08:24:02","slug":"clinomic-sets-course-for-growth-medtech-company-strengthens-leadership-team-for-international-scaling","status":"publish","type":"post","link":"https:\/\/www.clinomic.ai\/de\/2026\/03\/26\/clinomic-sets-course-for-growth-medtech-company-strengthens-leadership-team-for-international-scaling\/","title":{"rendered":"Clinomic Sets Course for Growth: MedTech Company Strengthens Leadership Team for International Scaling"},"content":{"rendered":"
\n
\"Bodo
Bodo Hubl (Chief Commercial Officer)<\/figcaption><\/figure>\n<\/div>\n\n\n

Aachen, March 26, 2026<\/strong> \u2013 Clinomic, a pioneer in data-driven critical care, has appointed experienced expert Bodo Hubl as its new Chief Commercial Officer (CCO). Working alongside a newly realigned commercial unit, Hubl will drive the expansion of Clinomic\u2019s European market leadership in the critical care segment and entry into new markets.<\/em><\/p>\n\n\n\n

Bodo Hubl brings extensive experience from senior roles in sales, operations, marketing, and partner management. Throughout his career, he has played a pivotal role in the growth and scaling of digital health companies, guiding their transformation from startups to scale-ups. His deep expertise in the hospital sector, strategic networking, and market development – combined with a proven track record of building high-performance teams – makes him the ideal choice for the CCO position at Clinomic.<\/p>\n\n\n\n

Hubl joins the leadership team around the two founders, Prof. Dr. med. Lukas Martin (CEO), and Dr. med. Arne Peine (CTO). He will lead a newly realigned commercial unit tasked with implementing the company’s strategic international growth targets. This appointment is a key step in Clinomic’s execution of the goals defined during its \u20ac23 million Series B financing round in 2025.<\/p>\n\n\n\n

„In Bodo Hubl, we have gained an experienced, strategic leader who will drive our vision of predictive, connected, and data-driven acute medicine with strong execution skills, positioning Clinomic as a leading driver of innovation,“ says Prof. Dr. med. Lukas Martin.<\/p>\n\n\n\n

\"Clinomic
Bodo Hubl (Chief Commercial Officer), Prof. Dr. med. Lukas Martin (CEO), Dr. med. Arne Peine (Chief Technology Officer)<\/figcaption><\/figure>\n\n\n\n

About Clinomic<\/strong><\/p>\n\n\n\n

Founded in 2019 as a spin-off from RWTH Aachen University Hospital, Clinomic is a MedTech company redefining critical care through connected intelligence. At the heart of its portfolio is Mona, an intelligent assistance platform. As a modular infrastructure for data-driven medicine, Mona optimizes clinical workflows – from documentation to treatment – using AI-supported, evidence-based insights. The company combines medical and technological expertise to ensure efficient processes and high-quality patient care. Clinomic currently employs more than 75 people across its locations in Aachen, Germany, and Cluj-Napoca, Romania. www.clinomic.ai<\/em><\/p>\n\n\n\n

<\/p>\n\n\n\n

Press Contacts<\/strong><\/p>\n\n\n\n

Clinomic<\/strong>
Christina Auffenberg
Senior Marketing & Communication Manager
press@clinomic.ai<\/a><\/td>		<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Download Press Release<\/strong><\/p>\n\n\n\n